Cargando…
Non-muscle Myosin II: Role in Microbial Infection and Its Potential as a Therapeutic Target
Currently, the major measures of preventing and controlling microbial infection are vaccinations and drugs. However, the appearance of drug resistance microbial mounts is main obstacle in current anti-microbial therapy. One of the most ubiquitous actin-binding proteins, non-muscle myosin II (NM II)...
Autores principales: | Tan, Lei, Yuan, Xiaomin, Liu, Yisong, Cai, Xiong, Guo, Shiyin, Wang, Aibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409350/ https://www.ncbi.nlm.nih.gov/pubmed/30886609 http://dx.doi.org/10.3389/fmicb.2019.00401 |
Ejemplares similares
-
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
por: Newell-Litwa, Karen A., et al.
Publicado: (2015) -
Metagenomic survey reveals global distribution and evolution of microbial sialic acid catabolism
por: Li, Yisong, et al.
Publicado: (2023) -
Nonmuscle Myosin Heavy Chain ⅡA-Mediated Exosome Release via Regulation of the Rho-Associated Kinase 1/Myosin Light Chains/Actin Pathway
por: Lv, Yanni, et al.
Publicado: (2020) -
Molecular control of non-muscle myosin II assembly
por: Juanes-García, Alba, et al.
Publicado: (2016) -
A myosin II nanomachine mimicking the striated muscle
por: Pertici, Irene, et al.
Publicado: (2018)